Contact Tracing During the COVID-19 Epidemic: Insights from the Experience of the Veneto Region in Italy.

Contact Tracing During the COVID-19 Epidemic: Insights from the Experience of the Veneto Region in Italy.

Publication date: Jan 30, 2025

Nonpharmaceutical public health interventions, such as contact tracing (CT), have been widely implemented worldwide to mitigate the spread of coronavirus disease 2019 (COVID-19). This study investigated the association between CT activity and COVID-19 cases, as well as the impact of timely contact with positive cases on hospitalizations in the Veneto region in northeastern Italy. Data sources included a CT-focused questionnaire, regional daily CT activity data, and a regional database of daily COVID-19 cases, hospitalizations, and intensive care unit (ICU) admissions. Negative binomial regression models were used to assess associations between CT activity and the number of positive cases, the number of hospitalizations, the time to contact cases, the number of positive cases traced, and the number of CT operators. Different organizational models (OMs) were compared in terms of their effectiveness. Hospitalization rates decreased by 54% when index cases were contacted within 0-1 days compared with a five-day delay in the first period. During periods of increasing case numbers, hospitalizations decreased to 8% for contact ranges of 0-1 and 2-4 days. The increase in CT activity showed a 60% increase in daily activity per 100 cases in the third period, excluding external CT activities. These results emphasize the critical role of prompt and effective CT in controlling the spread of infectious diseases and reducing the burden on health care systems. Further research is warranted to explore the potential benefits and limitations of different organizational models in the context of contact tracing and public health management, as well as in a cross-cultural comparison.

Open Access PDF

Concepts Keywords
Coronavirus contact tracing
Daily COVID-19
Hospitalizations hospitalizations
Italy organizational models
Nonpharmaceutical pandemic control

Semantics

Type Source Name
disease IDO contact tracing
disease MESH COVID-19
disease MESH Data sources
disease IDO role
disease MESH infectious diseases
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH sexually transmitted infections
disease MESH measles
pathway KEGG Measles
pathway REACTOME Reproduction
disease MESH infection
disease IDO susceptibility
drug DRUGBANK Tretamine
disease MESH emergencies
disease IDO symptom
disease IDO process

Original Article

(Visited 1 times, 1 visits today)